Review
Tumor-related interleukins: old validated targets for new anti-cancer drug development
Published on: 19 September 2017
Call for Papers: Special Issue 2017
Series Title: Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities
The series will cover all aspects related to expression, regulation and function of receptor tyrosine kinases (RTKs), non-receptor tyrosine kinases and other kinases in oncogenic signaling in cancer cells. Other topics of interest relate to targeted therapies, tyrosine kinase inhibitors (TKI), genetic and epigenetic mechanisms of acquired resistance to TKI, clinical trials and pre-clinical studies.
The journal encourage submission of original research articles and reviews. The deadline for all submission is October 15, 2017. To submit your manuscript, please use our online submission system available here.
When finalizing the submission, use the drop-down menu in the 'Additional Information' tab to specify that you are submitting to this special issue.
Articles
-
-
Research
-
Review
Cell-specific mechanisms of TMEM16A Ca2+-activated chloride channel in cancer
Published on: 11 September 2017
-
Review
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Published on: 30 August 2017
-
Research
-
Research
Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer
Published on: 28 September 2014
-
Research
-
Review
The complexity of NF-κB signaling in inflammation and cancer
Published on: 2 August 2013
-
Research
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Published on: 22 July 2010
-
Review
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Published on: 29 May 2014
Aims and scope
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Impact Factor
Molecular Cancer has an Impact Factor of 6.204. It is currently ranked at 36 out of 286 (Q1) in the Biochemistry and Molecular Biology category and 31 out of 217 (Q1) in the Oncology category of Journal Citation Reports.
Advertisement
